Beta blocker use after acute myocardial infarction in the patient with normal systolic function: When is it "ok" to discontinue?

Current Cardiology Reviews

Volumn 8, Issue 1, 2012, Pages 77-84

  Kezerashvili, Anna ^a   Marzo, Kevin ^a   de Leon, Joshua ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute myocardial infarction; Beta blockers; Secondary prevention

Indexed keywords

ATENOLOL; METOPROLOL;

ACUTE HEART INFARCTION; ANGINA PECTORIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION;

ADRENERGIC BETA-ANTAGONISTS; CLINICAL TRIALS AS TOPIC; HUMANS; METOPROLOL; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; SECONDARY PREVENTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84870163213     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340312801215764     Document Type: Review

References (57)

1. Lopez-Sendon J, Swedberg K, McMurray J, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004; 25[15]: 1341-62.
2. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med; 304[14]: 801-7.
3. Hawkins CM, Richardson DW, Vokonas PS. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. Circulation 1983; 67[6 Pt 2]: I94-7.
4. Olsson G, Rehnqvist N, Sjogren A, et al. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol 1985; 5[6]: 1428-37.
5. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339[8]: 489-97.
6. Freemantle N, Cleland J, Young P, et al. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318[7200]: 1730-7.
7. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet 1981; 2[8251]: 823-7.
8. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction]. Circulation 2004; 110[5]: 588-636.
9. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357[9266]: 1385-90.
10. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction] developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50[7]: e1-e157.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157[21]: 2413-46.
12. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery] Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50[17]: 1707-32.
13. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery]: developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation 2006; 113[22]: 2662-74.
14. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; [11]: 1341-81.
15. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135[12]: 1061-73.
16. Echahidi N, Pibarot P, O'Hara G, et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51[8]: 793-801.
17. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986; 57[12]: 43F-9F.
18. Lange R, Kloner RA, Braunwald E. First ultra-short-acting betaadrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs. Am J Cardiol 1983; 51[10]: 1759-67.
19. Mueller HS, Ayres SM. Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. J Clin Invest 1980; 65[2]: 338-46.
20. Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971; 43[1]: 67-82.
21. Reimer KA, Rasmussen MM, Jennings RB. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res 1973; 33[3]: 353-63.
22. Waldenstrom AP, Hjalmarson AC. Myocardial enzyme release from ischemic isolated perfused working rat heart. Recent Adv Stud Cardiac Struct Metab 1975; 10: 307-15.
23. Yusuf S, Peto R, Lewis J, Collins R, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27[5]: 335-71.
24. Hjalmarson A, Herlitz J. Limitation of infarct size by beta blockers and its potential role for prognosis. Circulation 1983; 67[6 Pt 2]: I68-71.
25. Waldenstrom AP, Hjalmarson AC. Factors modifying ischemic injury in the isolated rat heart. Acta Med Scand 1977; 201[6]: 533-8.
26. Norris RM, Barnaby PF, Brown MA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet 1984; 2[8408]: 883-6.
27. Rossi PR, Yusuf S, Ramsdale D, et al. Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. Br Med J [Clin Res Ed] 1983; 286[6364]: 506-10.
28. Ryden L, Ariniego R, Arnman K, et al. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 1983; 308[11]: 614-8.
29. Olsson G, Rehnqvist N. Evaluation of antiarrhythmic effect of metoprolol treatment after acute myocardial infarction: relationship between treatment responses and survival during a 3-year followup. Eur Heart J 1986; 7[4]: 312-9.
30. Ahumada GG, Karlsberg RP, Jaffe AS, et al. Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. Br Heart J 1979; 41[6]: 654-9.
31. Ramsdale DR, Faragher EB, Bennett DH, et al. Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. Am Heart J 1982; 103[4 Pt 1]: 459-67.
32. Waagstein F, Hjalmarson AC, Wasir HS. Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol. Br Heart J 1974; 36[11]: 1109-21.
33. Richterova A, Herlitz J, Holmberg S, et al. Goteborg Metoprolol Trial: effects on chest pain. Am J Cardiol 1984; 53[13]: 32D-6D.
34. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2[8498]: 57-66.
35. Metoprolol in acute myocardial infarction [MIAMI]. A randomised placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J 1985; 6[3]: 199-226.
36. Yusuf S, Lessem J, Jha P, et al. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. J Hypertens Suppl 1993; 11[4]: S61-73.
37. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22[17]: 1527-60.
38. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344[22]: 1651-8.
39. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure [MERIT-HF]. Lancet 1999; 353[9169]: 2001-7.
40. The Cardiac Insufficiency Bisoprolol Study II [CIBIS-II]: a randomised trial. Lancet 1999; 353[9146]: 9-13.
41. Pfisterer M, Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA [alteplase] for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 32[3]: 634-40.
42. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction [TIMI] II-B Study. Circulation 1991; 83[2]: 422-37.
43. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366[9497]: 1622-32.
44. Menon V, Slater JN, White HD, et al. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 2000; 108[5]: 374-80.
45. Al-Reesi A, Al-Zadjali N, Perry J, et al. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. CJEM 2008; 10[3]: 215-23.
46. Harjai KJ, Stone GW, Boura J, et al. Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2003; 91[6]: 655-60.
47. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group. JAMA 1981; 246[18]: 2073-4.
48. Pedersen TR. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med 1985; 313[17]: 1055-8.
49. Rehnqvist N, Olsson G. Beta-blockade after myocardial infarction: practical implications of major clinical trials. J Cardiovasc Pharmacol 1987; 10 Suppl 2: S10-4.
50. Viscoli CM, Horwitz RI, Singer BH. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness. Ann Intern Med 1993; 118[2]: 99-105.
51. Gheorghiade M, Schultz L, Tilley B, et al. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol 1990; 66[2]: 129-33.
52. Olsson G, Wikstrand J, Warnold I, et al. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992; 13[1]: 28-32.
53. Salathia KS, Barber JM, McIlmoyle EL, et al. Very early intervention with metoprolol in suspected acute myocardial infarction. Eur Heart J 1985; 6[3]: 190-8.
54. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group. Eur Heart J 1987; 8[10]: 1056-64.
55. Cucherat M, Boissel JP, Leizorovicz A. Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prevention Secondaire de l'Infarctus. Am J Cardiol 1997; 79[5]: 587-9.
56. Kernis SJ, Harjai KJ, Stone GW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 2004; 43[10]: 1773-9.
57. Halkin A, Grines CL, Cox DA, et al. Impact of intravenous betablockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 2004; 43[10]: 1780-7.